TRAITEMENT DU SYNDROME DE L'X FRAGILE
- 专利权人:
- UTI LIMITED PARTNERSHIP
- 发明人:
- TURNER, RAYMOND, W.
- 申请号：
- CA3088028
- 公开号：
- CA3088028A1
- 申请日:
- 2019.01.10
- 申请国别(地区):
- CA
- 年份:
- 2019
- 代理人:
- 摘要：
- The present disclosure relates generally to the treatment of Fragile X Syndrome using a recombinant fusion polypeptide comprising or consisting of a cell penetrating polypeptide, such as HIS or tat, and a Fragile X Mental Retardation protein (FMRP (298)).
- 来源网站：
- 中国工程科技知识中心
